Stockscreener 앱 받기
17.04
2.04%
0.34
Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스
How high can Eton Pharmaceuticals Inc. stock goPortfolio Profit Report & High Win Rate Trade Alerts - Newser
Chart overlay techniques for tracking Eton Pharmaceuticals Inc.Market Activity Recap & Risk Managed Trade Strategies - Newser
Visualizing Eton Pharmaceuticals Inc. stock with heatmapsJuly 2025 Chart Watch & Daily Market Momentum Tracking - Newser
Published on: 2025-08-15 17:26:08 - Newser
What does recent volatility data suggest for Eton Pharmaceuticals Inc.Market Performance Report & Verified Short-Term Trading Plans - Newser
What institutional flow reveals about Eton Pharmaceuticals Inc.Market Sentiment Report & Community Trade Idea Sharing Platform - Newser
What makes Eton Pharmaceuticals Inc. stock price move sharply2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
How Eton Pharmaceuticals Inc. stock reacts to Fed policy changesJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Is Eton Pharmaceuticals Inc. forming a bullish divergenceJuly 2025 Retail & Low Risk High Reward Trade Ideas - sundaytimes.kr
What data driven models say about Eton Pharmaceuticals Inc.’s futureWeekly Risk Summary & Long-Term Capital Growth Ideas - Newser
Is Eton Pharmaceuticals Inc. trending in predictive chart models2025 Biggest Moves & Safe Swing Trade Setups - Newser
Identifying reversal signals in Eton Pharmaceuticals Inc.2025 Valuation Update & High Accuracy Trade Alerts - Newser
XTX Topco Ltd Sells 2,858 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Why Eton Pharmaceuticals Inc. is moving todayMarket Movement Recap & Community Supported Trade Ideas - Newser
Eton Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming - Newser
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Published on: 2025-08-13 17:16:40 - sundaytimes.kr
How to interpret RSI for Eton Pharmaceuticals Inc. stock [Gap Up]Free Low Drawdown Trading Techniques - Newser
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2025 Earnings Call Transcript - Insider Monkey
With 43% Ownership in Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Institutional Investors Have a Lot Riding on the Business - 富途牛牛
Loss-Making Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Set To Breakeven - simplywall.st
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates - MSN
Eton Pharmaceuticals Experiences Record Revenue Growth and Analysts See Significant Upside Potential - AInvest
Eton targets $80M revenue run-rate in Q3 2025 as product launches accelerate - MSN
Tools to monitor Eton Pharmaceuticals Inc. recovery probabilityWeekly Breakout Forecast with Entry Zones - Newser
Is Eton Pharmaceuticals Inc. stock reversal real or fakeTrade Safety Matrix for Conservative Traders - Newser
Eton (ETON) Q2 Revenue Jumps 108% - AOL.com
Quantitative breakdown of Eton Pharmaceuticals Inc. recent moveFree Stock Selection With High Accuracy - Newser
Wall Street Zen Downgrades Eton Pharmaceuticals (NASDAQ:ETON) to Hold - Defense World
Published on: 2025-08-08 22:55:40 - Newser
Eton Pharmaceuticals 2025 Q2 Earnings Narrowed Losses and Strong Revenue Growth - AInvest
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth By Investing.com - Investing.com Canada
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth - Investing.com
Eton Pharmaceuticals Soars 17.23% on 108% Sales Growth - AInvest
Analyzing Eton Pharmaceuticals: A Reasonable Growth Opportunity with Affordable Pricing and Potential Upside from Options. - AInvest
Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options - Seeking Alpha
Eton Pharmaceuticals Inc (ETON) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Eton Pharmaceuticals Reports Robust Q2 2025 Growth - TipRanks
Real time pattern detection on Eton Pharmaceuticals Inc. stockBuy/Sell Zone Confirmation Technical Analysis - Newser
Eton Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Eton Pharmaceuticals reports Q2 non-GAAP EPS 3c, consensus 2c - TipRanks
Eton Pharmaceuticals earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewswire
Eton Pharmaceuticals Earnings: 108% Revenue Jump and Early Milestone Achievement Signals Breakout Growth - Stock Titan
Signal strength of Eton Pharmaceuticals Inc. stock in tech scannersLow Risk High Confidence Watchlist Builder - Newser
Smart tools for monitoring Eton Pharmaceuticals Inc.’s price actionAI-Powered Stock Trend Movement Analysis - Newser
Quant Tools Rank Eton Pharmaceuticals Inc. as High Risk High RewardVerified Signal From Chart Patterns Detected - beatles.ru
How does Eton Pharmaceuticals Inc. compare to its industry peersMarket-leading profit generation - Jammu Links News
2.80%
0.22%
자본화:
|
볼륨(24시간):